A new research paper recently published gives further weight to the eradication of the transrectal (
A new research paper recently published in the peer-reviewed urology journal, BJU International, gives further weight to the eradication of the transrectal (TR) prostate biopsy from the prostate cancer pathway. The study, in which the authors evaluated nearly half a million prostate biopsies in the NHS over the last decade, gives sufficient evidence for the distinct advantages of the transperineal (TP) route over the TR route in terms of reduced infections and burden of expen
New study adds evidence to the important role of MRI & systematic biopsy in prostate cancer diag
A new study published in the American Urological Association Journal of Urology adds the largest cohort data to the body of literature for MRI in active surveillance of prostate cancer. The study, funded by the Canary Foundation, investigated the ability of prostate MRI to detect Gleason Grade Group (GG) ≥2 cancer in a standardised, multi-institutional active surveillance cohort and concluded with the recommendation of systematic biopsy in patients with a negative MRI and the
Patients treated with Low Dose Rate Brachytherapy boost therapy in combination with External Beam Ra
New original research from Leeds Teaching Hospitals NHS Trust, as published in Elsevier’s Journal of Clinical and Translational Radiation Oncology, has revealed that men with intermediate- and high-risk prostate cancer treated with a low dose rate brachytherapy boost in combination with external beam radiotherapy (LDR-EBRT) achieve more effective PSA control over a five year post-treatment period than men treated with a high dose rate brachytherapy boost (HDR-EBRT). Dose esca
